Keyword Analysis & Research: sanofi immunology pipeline
Keyword Research: People who searched sanofi immunology pipeline also searched
Search Results related to sanofi immunology pipeline on Search Engine
-
Our Healthcare Pipeline - Research, R&D portfolio - Sanofi
https://www.sanofi.com/en/our-science/our-pipeline
webFeb 1, 2024 · With a strong focus on difficult-to-treat diseases and immunization, our R&D pipeline includes 83 clinical-stage projects, 30 of which are in phase 3 or have been …
DA: 62 PA: 69 MOZ Rank: 77
-
Press Release: Sanofi Pipeline Transformation to Accelerate …
https://www.sanofi.com/en/media-room/press-releases/2023/2023-12-07-02-30-00-2792186
webDec 7, 2002 · Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in …
DA: 52 PA: 24 MOZ Rank: 74
-
Sanofi kicks off new immunology research journey with Stanford …
https://www.fiercebiotech.com/biotech/sanofi-kicks-off-new-immunology-drug-discovery-journey-stanford-pact
webMay 6, 2021 · Drugs often take more than a decade to move through the pipeline, and Sanofi is kicking off the process anew in immunology through a scientific exchange …
DA: 62 PA: 45 MOZ Rank: 25
-
Press Release: Sanofi Delivers Solid Sales and Business EPS …
https://www.sanofi.com/en/media-room/press-releases/2024/2024-02-01-06-30-00-2821667
webFeb 1, 2006 · Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline. Paris, …
DA: 23 PA: 42 MOZ Rank: 66
-
Sanofi Ups Immunology Game With $1.4 Billion …
https://www.biospace.com/article/sanofi-boosts-immunology-pipeline-with-1-4-billion-acquisition-of-kymab/
webJan 11, 2021 · French pharma giant Sanofi kicks off 2021 with a $1.4 billion cash acquisition of U.K.-based Kymab to bolster the company’s presence in immunology. The deal adds Kymab’s lead asset KY1005 to its pipeline, …
DA: 16 PA: 61 MOZ Rank: 85
-
Sanofi chalks up another win for its immune system research
https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-study-results-immunology-kymab/654027/
webPublished June 27, 2023. Jacob Bell Senior Reporter. Courtesy of Sanofi. An experimental drug that Sanofi paid more than a billion dollars to acquire has scored positive results in …
DA: 3 PA: 7 MOZ Rank: 29
-
Sanofi Pipeline Transformation to Accelerate Growth Driven by …
https://www.pharmiweb.com/pwtoday-story/sanofi-pipeline-transformation-to-accelerate-growth-driven-by-record-number-of-potential-blockbuster-launches-paving-the-way-to-industry-leadership-in-immunology
webDec 8, 2023 · Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with €2 to 5 billion peak …
DA: 56 PA: 95 MOZ Rank: 61